1. Home
  2. MATH vs INTS Comparison

MATH vs INTS Comparison

Compare MATH & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MATH
  • INTS
  • Stock Information
  • Founded
  • MATH 2015
  • INTS 2012
  • Country
  • MATH Hong Kong
  • INTS United States
  • Employees
  • MATH N/A
  • INTS N/A
  • Industry
  • MATH Finance/Investors Services
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • MATH Finance
  • INTS Health Care
  • Exchange
  • MATH Nasdaq
  • INTS Nasdaq
  • Market Cap
  • MATH 41.1M
  • INTS 33.4M
  • IPO Year
  • MATH N/A
  • INTS 2023
  • Fundamental
  • Price
  • MATH $2.12
  • INTS $2.23
  • Analyst Decision
  • MATH
  • INTS Strong Buy
  • Analyst Count
  • MATH 0
  • INTS 3
  • Target Price
  • MATH N/A
  • INTS $8.50
  • AVG Volume (30 Days)
  • MATH 308.8K
  • INTS 26.6K
  • Earning Date
  • MATH 10-31-2024
  • INTS 03-13-2025
  • Dividend Yield
  • MATH N/A
  • INTS N/A
  • EPS Growth
  • MATH N/A
  • INTS N/A
  • EPS
  • MATH 0.17
  • INTS N/A
  • Revenue
  • MATH $31,399,049.00
  • INTS N/A
  • Revenue This Year
  • MATH N/A
  • INTS N/A
  • Revenue Next Year
  • MATH N/A
  • INTS N/A
  • P/E Ratio
  • MATH $12.71
  • INTS N/A
  • Revenue Growth
  • MATH 291.58
  • INTS N/A
  • 52 Week Low
  • MATH $0.80
  • INTS $1.50
  • 52 Week High
  • MATH $2.78
  • INTS $5.94
  • Technical
  • Relative Strength Index (RSI)
  • MATH 57.93
  • INTS 49.26
  • Support Level
  • MATH $2.01
  • INTS $1.84
  • Resistance Level
  • MATH $2.78
  • INTS $2.27
  • Average True Range (ATR)
  • MATH 0.26
  • INTS 0.28
  • MACD
  • MATH 0.03
  • INTS -0.01
  • Stochastic Oscillator
  • MATH 50.30
  • INTS 56.36

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

Share on Social Networks: